FR20C1026I1 - Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux - Google Patents

Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux

Info

Publication number
FR20C1026I1
FR20C1026I1 FR20C1026C FR20C1026C FR20C1026I1 FR 20C1026 I1 FR20C1026 I1 FR 20C1026I1 FR 20C1026 C FR20C1026 C FR 20C1026C FR 20C1026 C FR20C1026 C FR 20C1026C FR 20C1026 I1 FR20C1026 I1 FR 20C1026I1
Authority
FR
France
Prior art keywords
ciclesonide
horses
diseases
treatment
respiratory tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR20C1026C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR20C1026(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of FR20C1026I1 publication Critical patent/FR20C1026I1/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
FR20C1026C 2012-12-21 2020-06-26 Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux Active FR20C1026I1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses
EP13811924.3A EP2934479B1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
FR20C1026I1 true FR20C1026I1 (fr) 2020-10-02

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20C1026C Active FR20C1026I1 (fr) 2012-12-21 2020-06-26 Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux

Country Status (24)

Country Link
US (4) US9918995B2 (no)
EP (1) EP2934479B1 (no)
AR (1) AR094241A1 (no)
AU (2) AU2013360691B2 (no)
BR (2) BR112015010842B1 (no)
CA (1) CA2888428C (no)
CY (2) CY1121115T1 (no)
DK (1) DK2934479T3 (no)
ES (1) ES2693779T3 (no)
FR (1) FR20C1026I1 (no)
HR (1) HRP20181980T1 (no)
HU (1) HUS2000020I1 (no)
IN (1) IN2015DN02894A (no)
LT (2) LT2934479T (no)
MA (1) MA38169B2 (no)
MX (1) MX368306B (no)
NO (1) NO2020014I1 (no)
NZ (1) NZ706573A (no)
PL (1) PL2934479T3 (no)
PT (1) PT2934479T (no)
RS (1) RS57740B1 (no)
SI (1) SI2934479T1 (no)
WO (1) WO2014096115A1 (no)
ZA (1) ZA201502288B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
DK3473255T3 (da) 2012-12-21 2022-04-04 Boehringer Ingelheim Vetmedica Gmbh Farmaceutisk formulering omfattende ciclesonid
PL3157522T3 (pl) 2014-06-18 2020-03-31 Boehringer Ingelheim Vetmedica Gmbh Antagonisty muskarynowi i ich kombinacje do leczenia choroby dróg oddechowych u koni
US11191746B2 (en) * 2016-10-14 2021-12-07 Jeju National University Industry-Academic Cooperation Foundation Composition for inhibiting a growth of cancer stem cells comprising ciclesonide
US20230033224A1 (en) * 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
BR112023001689A2 (pt) 2020-07-31 2023-05-02 Chemo Res S L Terapia de combinação para administração por inalação

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
WO2004023984A2 (en) 2002-09-13 2004-03-25 Smith C Steven Novel composition and method for treatment of upper respiratory conditions
CA2525943A1 (en) 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
AU2005235384B2 (en) 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
JP2008504341A (ja) 2004-06-29 2008-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドと抗コリン作用剤とを含む吸入用薬剤
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SG176961A1 (en) 2009-06-25 2012-02-28 Boehringer Ingelheim Vetmed Inhaler
US7829748B1 (en) * 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
US20150202297A1 (en) 2012-07-05 2015-07-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
DK3473255T3 (da) 2012-12-21 2022-04-04 Boehringer Ingelheim Vetmedica Gmbh Farmaceutisk formulering omfattende ciclesonid
ES2960809T3 (es) 2013-08-20 2024-03-06 Boehringer Ingelheim Vetmedica Gmbh Inhalador
EP3035886B1 (en) 2013-08-20 2020-10-07 Boehringer Ingelheim Vetmedica GmbH Inhaler
PL3157522T3 (pl) 2014-06-18 2020-03-31 Boehringer Ingelheim Vetmedica Gmbh Antagonisty muskarynowi i ich kombinacje do leczenia choroby dróg oddechowych u koni

Also Published As

Publication number Publication date
US20180153907A1 (en) 2018-06-07
BR112015010842A8 (pt) 2019-10-01
HUS2000020I1 (hu) 2020-07-28
AU2018201642A1 (en) 2018-03-29
PL2934479T3 (pl) 2019-02-28
US10258634B2 (en) 2019-04-16
LTPA2020511I1 (lt) 2020-07-27
NZ706573A (en) 2019-11-29
EP2934479B1 (en) 2018-09-19
LT2934479T (lt) 2018-12-27
MX2015007947A (es) 2015-10-08
DK2934479T3 (en) 2018-11-05
PT2934479T (pt) 2018-12-20
EP2934479A1 (en) 2015-10-28
CY2020015I1 (el) 2020-11-25
BR112015010842A2 (pt) 2017-07-11
RS57740B1 (sr) 2018-12-31
HRP20181980T1 (hr) 2019-01-25
NO2020014I1 (no) 2020-06-12
BR122016029247A2 (pt) 2019-08-20
AR094241A1 (es) 2015-07-22
ZA201502288B (en) 2019-09-25
AU2018201642B2 (en) 2019-01-31
MA38169B2 (fr) 2021-08-31
SI2934479T1 (sl) 2019-01-31
AU2013360691B2 (en) 2018-03-08
US9918995B2 (en) 2018-03-20
MX368306B (es) 2019-09-27
AU2013360691A1 (en) 2015-04-16
IN2015DN02894A (no) 2015-09-11
CY1121115T1 (el) 2019-12-11
ES2693779T3 (es) 2018-12-13
BR112015010842B1 (pt) 2021-03-30
MA38169A1 (fr) 2017-01-31
US10441597B2 (en) 2019-10-15
WO2014096115A1 (en) 2014-06-26
CA2888428A1 (en) 2014-06-26
CY2020015I2 (el) 2021-03-12
US20170079988A1 (en) 2017-03-23
US20150313918A1 (en) 2015-11-05
US20140179651A1 (en) 2014-06-26
CA2888428C (en) 2021-07-13

Similar Documents

Publication Publication Date Title
FR20C1026I1 (fr) Ciclesonide pour le traitement de maladies des voies respiratoires chez les chevaux
GB2492487B (en) Cannabinoids for use in the treatment of neurodegenerative diseases or disorders
EA201991484A1 (ru) Лекарственные формы энзалутамида
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
EP2911664A4 (en) COMBINATION THERAPIES FOR THE TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES
IL236920B (en) Ophthalmic compositions and their use for treatment of eye diseases and disorders in animals
FR2948687B1 (fr) Utilisation de microarn pour le traitement de pathologies respiratoires chroniques
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
IL268757A (en) Pharmaceutical preparations containing 7-(H1-imidazol-4-ylmethyl)-8,7,6,5-tetrahydroquinoline for the treatment of skin diseases and conditions
MA39950A (fr) Dérivé de 2-acylaminothiazole pour le traitement des maladies des voies urinaires et de la vessie
IL237730B (en) Treatment of mild and moderate Alzheimer's disease
PL2874600T3 (pl) Kompozycja farmaceutyczna do leczenia chrypki lub bólów gardła.
HUE038580T2 (hu) Hatóanyag bejuttató rendszer neurológiai rendellenességek kezelésében, vagy diagnózisában való felhasználásra
PL2774991T3 (pl) System dostarczania leków do stosowania w leczeniu lub diagnostyce zaburzeń neurologicznych
IL239078A0 (en) Protein for use in the treatment of eye diseases
FR2992219B1 (fr) Composition pour le traitement de l'hypocalcemie chez les ruminants
FR2992315B1 (fr) Derives utiles dans le traitement de maladies du systeme nerveux central
FR2976807B1 (fr) Composition pharmaceutique pour le traitement de la dependance chez l'etre humain
ZA201306759B (en) Compounds for use in imaging,diagnosing and/or treatment of diseases of the central nervous system
FR2976493B1 (fr) Electrode combinee pour le traitement de l'hyperhidrose
FR2985907B1 (fr) Composition pharmaceutique pour le traitement des dysfonctions erectiles
FR2974182B1 (fr) Diagnostic et traitement de l'angioedeme
HUP1300454A2 (hu) Daganatos betegségek gyógyítására és megelõzésére alkalmas gyógyászati készítmények, és eljárás azok elõállítására